Ignite Creation Date:
2025-12-24 @ 9:41 PM
Ignite Modification Date:
2026-01-02 @ 2:04 PM
Study NCT ID:
NCT03777332
Status:
COMPLETED
Last Update Posted:
2021-11-10
First Post:
2018-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety of Intravitreal APL-2 in Patients Diagnosed With Geographic Atrophy
Sponsor:
Apellis Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-05
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-01
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-14
First Submit QC Date:
None
Study First Post Date:
2018-12-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-08
Last Update Post Date:
2021-11-10
Last Update Post Date Type:
ACTUAL